Skip to main content

Advertisement

ADVERTISEMENT

News

News
10/03/2023

Acutus Medical Press Release 

Acutus Medical Press Release 
CARLSBAD, Calif., Oct. 02, 2023  -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on...
CARLSBAD, Calif., Oct. 02, 2023  -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on...
CARLSBAD, Calif., Oct. 02,...
10/03/2023
EP Lab Digest
News
10/03/2023

The American College of Cardiology Press Release 

The American College of Cardiology Pr...
New workbook is roadmap to providing quality basic and advanced CV care in the home
New workbook is roadmap to providing quality basic and advanced CV care in the home
New workbook is roadmap to...
10/03/2023
EP Lab Digest
News
10/03/2023

MicroPort Press Release 

MicroPort Press Release 
Clamart, France, October 02, 2023 – MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France with Global Operations, is pleased to announce the launch of the ULYS™ Implantable Cardioverter...
Clamart, France, October 02, 2023 – MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France with Global Operations, is pleased to announce the launch of the ULYS™ Implantable Cardioverter...
Clamart, France, October 02,...
10/03/2023
EP Lab Digest

Advertisement

News
10/02/2023

Anumana News

Anumana News
Developed in partnership with Mayo Clinic, Anumana’s ECG-AI LEF is an innovative software-as-a-medical device (SaMD) designed to screen for LEF in adults at risk for heart failure using data from a routine 12-lead electrocardiogram (ECG).
Developed in partnership with Mayo Clinic, Anumana’s ECG-AI LEF is an innovative software-as-a-medical device (SaMD) designed to screen for LEF in adults at risk for heart failure using data from a routine 12-lead electrocardiogram (ECG).
Developed in partnership with...
10/02/2023
Cath Lab Digest
News
09/29/2023

Viz.ai Press Release

Viz.ai Press Release
Expansion brings AI-powered care coordination to underserved communities for clinical trial recruitment
Expansion brings AI-powered care coordination to underserved communities for clinical trial recruitment
Expansion brings AI-powered care...
09/29/2023
EP Lab Digest
News
09/29/2023

 Pulse Biosciences Press Release 

 Pulse Biosciences Press Release  ...
HAYWARD, CA - September 29, 2023 - Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial...
HAYWARD, CA - September 29, 2023 - Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial...
HAYWARD, CA - September 29, 2023...
09/29/2023
EP Lab Digest

Advertisement

News
09/26/2023

iRhythm Press Release 

iRhythm Press Release 
iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S.
iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S.
iRhythm is launching its next...
09/26/2023
EP Lab Digest
News
09/26/2023

Kestra Medical Technologies Press Release 

Kestra Medical Technologies Press Rel...
New ASSURE WCD Enhanced Arrythmia Capabilities Featured
New ASSURE WCD Enhanced Arrythmia Capabilities Featured
New ASSURE WCD Enhanced...
09/26/2023
EP Lab Digest
News
09/26/2023

Viz.ai Press Release 

Viz.ai Press Release 
Expansion brings AI-powered care coordination to underserved communities for clinical trial recruitment
Expansion brings AI-powered care coordination to underserved communities for clinical trial recruitment
Expansion brings AI-powered care...
09/26/2023
EP Lab Digest

Advertisement

News
09/25/2023

Attune Medical Press Release 

Attune Medical Press Release 
Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac...
Attune Medical has been granted De Novo marketing authorization from the US Food and Drug Administration (FDA) for its ensoETM device to reduce the likelihood of ablation-related esophageal injury resulting from radiofrequency cardiac...
Attune Medical has been granted...
09/25/2023
EP Lab Digest

Advertisement